Home/Filings/4/0001209191-22-060501
4//SEC Filing

HAMILTON CHRISTINE E 4

Accession 0001209191-22-060501

CIK 0001833214other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:31 PM ET

Size

9.6 KB

Accession

0001209191-22-060501

Insider Transaction Report

Form 4
Period: 2022-12-07
HAMILTON CHRISTINE E
Director10% Owner
Transactions
  • Award

    Common Stock

    2022-12-07$1.21/sh+82,987$99,9993,111,334 total(indirect: By Spouse)
  • Award

    Warrant (Common Stock)

    2022-12-07+82,98782,987 total(indirect: By Spouse)
    Exercise: $1.08From: 2023-06-07Exp: 2027-12-07Common Stock (82,987 underlying)
Holdings
  • Common Stock

    4,993,090
Footnotes (3)
  • [F1]On December 6, 2022, the Registrant entered into a securities purchase agreement with Ms. Christine Hamilton and Dr. Edward Hamilton in connection with a private placement conducted by the Registrant, pursuant to which Ms. Hamilton and Dr. Hamilton purchased (i) an aggregate of 82,987 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance.
  • [F2]Reflects dispositions of 2,000,000 shares of common stock by Ms. Hamilton's spouse for bona fide estate planning purposes exempt from the report requirements of Section 16 under the Securities Exchange Act of 1934, as amended.
  • [F3]Does not include: (i) 25,000 shares of common stock held by Christensen Investments, LLC, (ii) 2,909,022 shares of common stock held by the reporting persons spouse, Dr. Edward Hamilton, and (iii) 91,261 shares of common stock which the reporting person co-owns with Dr. Hamilton, all of which the reporting person may be deemed to beneficially own. The reporting person disclaims any beneficial ownership of these shares of common stock other than to the extent of any pecuniary interests the reporting person may have therein.

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001216114

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:31 PM ET
Size
9.6 KB